Fundraising Fox
Nostics
Founded 2020 · 31 employees on LinkedIn · 1 known investors
Find your way into Nostics
Sign up to see every warm intro you have to Nostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nostics develops a portable optical biosensor that measures real-time spectral signals from pathogens in patient samples, using its Spectral Foundation Model to identify infections at the point of care in under 10 minutes. The platform targets healthcare providers seeking rapid, lab-comparable infection diagnostics for decentralized settings and to address antimicrobial resistance.
Founders & leadership
Nostics was founded in 2020 by Rochelle Niemeijer and Jeroen Nieuwenhuis.
JN
Jeroen NieuwenhuisCEOJeroen Nieuwenhuis is CEO of Nostics and brings over 15 years of medical diagnostics experience, including prior roles leading R&D teams at Philips and Siemens Healthineers where he worked on product development and intellectual property management.
Investors · 1
In the news
Frequently asked questions
- What does Nostics do?
- Nostics develops a portable optical biosensor that measures real-time spectral signals from pathogens in patient samples, using its Spectral Foundation Model to identify infections at the point of care in under 10 minutes. The platform targets healthcare providers seeking rapid, lab-comparable infection diagnostics for decentralized settings and to address antimicrobial resistance.
- Who founded Nostics?
- Nostics was founded by Rochelle Niemeijer, Jeroen Nieuwenhuis in 2020.
- Who are Nostics's investors?
- Nostics's investors include DFF Ventures.